TOKYO--(BUSINESS WIRE)--Teijin Pharma Limited (Head office: Tokyo; President: Osamu Nishikawa) announced that it has agreed to establish a 50-50 joint venture with Laboratorios del Dr. Esteve S.A. (hereafter “Esteve”), a major Spanish pharmaceutical company, to enter the home respiratory therapy business in Europe, beginning in Spain.
